Angioplasty or stenting for deep venous thrombosis
49 results
1 - 49
Compression stockings prevent postthrombotic syndrome in patients with DVT- LMWH better than UFH for acute DVT
- LMWH = UFH for thrombocytopenia
- Aspirin prevents recurrent venous thromboembolism
- Idraparinux effective for DVT but not for PE
- Guidelines for managing VTE (AAFP, ACP)
- Thigh-length stockings better for DVT prevention in hospitalized stroke patients (CLOTS-2)
- Guidelines for the clinical diagnosis of VTE (AAFP, ACP)
- Guidewire exchange of PICCs associated with higher risk of thrombosis
- Optimal algorithm for evaluating suspected DVT
- LMWH better than unfractionated heparin for preventing DVT in medical patients
- Serial proximal vein ultrasonography + D-dimer = whole-leg Doppler for suspected leg DVT
- Rosuvastatin prevents DVT at very high cost
- Stockings plus anticoagulation more effective to prevent post-op VTE, but anticoagulation increases bleeding
- Both upper-extremity and lower-extremity DVT risk increased with PICCs
- D-dimer vs ultrasound for DVT: use prediction rule
- Sulodexide given long-term may reduce recurrent VTE in patients with initial unprovoked VTE
- Low-dose aspirin not useful for venous ulcers
- Genotype-guided perioperative warfarin dosing may not be superior to algorithm-guided dosing
- Risk of recurrent venous thromboembolism is 3% in patients with subsegmental pulmonary embolism who are not anticoagulated
- Early endovenous ablation improves outcomes in patients with venous leg ulcers
- Updated American College of Chest Physicians guideline on antithrombotic therapy for venous thromboembolism
- Twice as many complications associated with PICCs than with midline catheters for short-term use
- Dabigatran safe and effective for VTE
- Optimal treatment of acute venous thromboembolism
- Aspirin alone may be sufficient protection from postop VTE after total knee arthroplasty
- Edoxaban noninferior to warfarin for venous thromboembolism anticoagulation
- Dabigatran associated with increased risk of coronary events
- Femoral lines not associated with increased risk of bloodstream infections
- Reduced-dose apixaban noninferior to full dose for cancer-associated VTE after 6 months, with less bleeding
- Wells score plus age-adjusted d-dimer rules out more PEs
- Apixaban is noninferior to dalteparin for venous thromboembolism associated with cancer
- Prevalence of pulmonary embolism is 5.9% in patients with COPD who are hospitalized with acute respiratory symptoms
- Greater benefit with rivaroxaban than aspirin for extended treatment of VTE
- Normal hs troponin and PESI score of 0 means great prognosis for PE
- Epoetin alfa does not reduce transfusions in critically ill
- Compression stockings unnecessary for inpatients who undergo elective surgery
- No benefit to extended VTE prophylaxis with apixaban in hospitalized medical patients (ADOPT)
- D-dimer can identify high-risk group for extended anticoagulation (PROLONG)